A record of what ETMarkets Analysis said publicly, with the source. Not advice.
“Bullish on Fortis Healthcare, suggesting short-term traders consider buying the stock for a target of ₹1,045 in the next few weeks. The stock has been in an uptrend since January 2025, hitting a record high in August, and chart patterns indicate the rally is likely to continue.”
ETMarkets Analysis’s track record (trackable calls only): 193 graded calls · 95% CI 23–35%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹1,045, as stated.
Window: 30 days, from the call's own horizon word ("short-term trade").
Neither the target ₹1,045 was reached on a close by the end of the window. Miss.
The grader’s working: R4 TARGET_CALL: entered ₹938.25 on 2025-08-18 (next trading session's close); neither target nor stop reached by window end 2025-09-13. Window 30 days — rule H4: the quote says "short-term trade" (short-term 30 days, medium-term 90, long-term 12 months).
How it played out
How this is worked out- Time to target
- The target was not reached on a close inside the window.
- Worst close against it
- The closing price went as far as 2.86% against the call up to 13 Sep 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.